Investor Relations
Welcome to Alzinova AB’s IR pages.
Alzinova AB is a company specializing in the treatment of Alzheimer’s disease – one of our major health scourges, without effective treatment options.
Latest press releases
- 2021-05-19 | Regulatory Alzinova AB interim report January – March 2021
- 2021-05-18 | Regulatory Bulletin from the annual general meeting of Alzinova AB (publ)
Latest news
- 2021-06-09 Sweden Bio interview with CEO Kristina Torfgård
- 2021-06-08 FDA's decision to approve aducanumab for the treatment of Alzheimer's disease